Green tea mist tested to fight COVID in vulnerable cancer patients
NCT ID NCT06924749
Summary
This study tested whether inhaling a mist containing EGCG, a compound from green tea, could help treat COVID-19 pneumonia in people who also have cancer. It involved 111 participants who were randomly assigned to receive either the EGCG treatment or a placebo. Researchers looked at whether the treatment improved lung scans and reduced COVID-19 symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanxi Zhao
Jinan, Shandong, Shandong Cancer Hospital, China
-
Shan Dong cancer hospital and institute
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.